Hodgkin's lymphoma, also known as Hodgkin's disease, develops mainly in young adults and is considered a very treatable cancer. In this Patient Power program, sponsored by The University of Texas M. D. Anderson Cancer Center you’ll hear from two inspiring patients and their doctors,as they discuss the latest in the treatment and research of Hodgkin’s disease and, in particular, new hope for people whose Hodgkin's disease has relapsed.
The program opens with 19-year-old Alexandra. She talks about her initial diagnosis several years ago, how it affected her life and her treatment at M. D. Anderson. When her cancer recurred, she returned to M. D. Anderson and is currently participating in a clinical trial. Next we hear from Brandy, a 36-year-old whose Hodgkin’s disease recurred in 2007. That’s when she sought treatment at M. D. Anderson. Both Brandy and Alexandra discuss their specific treatments, and speak highly of not only the care they have received but of the relationships they have formed with their respective physicians.
Dr. Ana Younes, director of the clinical and translational research program in the department of lymphoma/myeloma at M. D. Anderson, joins the program to help listeners understand Hodgkin’s disease. Dr. Michelle Fanale, assistant professor in the department of lymphoma/myeloma, discusses treatment approaches, clinical trials and varying responses to therapy. She also shares specific details of the therapies that Alexandra and Brandy have received. Both experts share their perspective on research and the outlook for the future of Hodgkin’s disease treatment. If you’ve been looking for information about Hodgkin’s disease, this program is a great educational resource.
Anas Younes, M.D.
Professor of Lymphoma/Myeloma, MD Anderson Cancer CenterDr. Anas Younes is Professor and Director of the Clinical and Translational Research Program in the Department of Lymphoma/Myeloma, Division of Cancer Medicine at M. D. Anderson Cancer Center in Houston, Texas. He completed his medical degree at the The University of Damascus School of Medicine followed by postgraduate training at Memorial Sloan-Kettering Cancer Center, The State University of New... more >
Michelle Fanale, M.D.
Assistant Professor, Lymphoma/Myeloma, MD Anderson Cancer CenterDr. Michelle A. Fanale is Assistant Professor in the Department of Lymphoma/Myeloma, Division of Cancer Medicine at The University of Texas M. D. Anderson Cancer Center in Houston, Texas. Dr. Fanale received her medical degree from the University of Medicine and Dentistry of New Jersey followed by a residency at the Mayo Clinic and a fellowship in medical oncology and... more >